Home
Conditions
Pneumococcal Vaccines

Clinical trial condition

Pneumococcal Vaccines

Explore clinical trials studying Pneumococcal Vaccines. Study availability and eligibility vary by location and protocol.

23 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Pneumococcal Vaccines trial results

Recruiting

A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

NCT06608199

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: Faculty of Medicine Udayana University Denpasar, Bali, Indonesia

Universitas Padjadjaran Bandung Bandung, Indonesia

Faculty of Medicine, padjadjaran University Bandung, Indonesia

View Trial Details

Not Yet Recruiting

Opportunistic Pneumococcal Immunisation Trial in MALnutrition

NCT06817421

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +12 more
Locations: Guido Valadares National Hospital (HNGV) Dili, Timor-Leste

View Trial Details

Not Yet Recruiting

Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans

NCT06271681

Conditions: Immunosuppression, Pneumococcal Vaccines
Locations: Not specified

View Trial Details

Completed

Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine

NCT06703203

Conditions: Pneumococcal Vaccines
Locations: Henan Provincial Center for Disease Control and Prevention Shangqiu, Henan, China

View Trial Details

Completed

Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

NCT06077656

Conditions: Pneumococcal Vaccines
Locations: Inventprise Clinical Site Vancouver, British Columbia, Canada

Inventprise Clinical Site Halifax, Nova Scotia, Canada

Inventprise Clinical Site Truro, Nova Scotia, Canada

Inventprise Clinical Site Saint-Louis, Quebec, Canada

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

NCT05844423

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
Locations: The Children's Clinic of Jonesboro, P.A. Jonesboro, Arkansas, United States

Madera Family Medical Group Madera, California, United States

Jedidiah Clinical Research Tampa, Florida, United States

Kentucky Pediatric/ Adult Research Bardstown, Kentucky, United States

View all 32 locations

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

NCT06151288

Conditions: Pneumococcal Vaccines
Locations: AMR Mobile Mobile, Alabama, United States

AMR Phoenix Phoenix, Arizona, United States

Research Centers of America Hollywood, Florida, United States

Health Awareness Jupiter, Florida, United States

View all 25 locations

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults

NCT05297578

Conditions: Pneumococcal Vaccines
Locations: Accel Research Sites-Birmingham Clinical Research Unit Birmingham, Alabama, United States

Accel Research Sites - DeLand Clinical Research Unit DeLand, Florida, United States

CenExel RCA Hollywood, Florida, United States

Precision Clinical Research Sunrise, Florida, United States

View all 20 locations

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults

NCT05266456

Conditions: Pneumococcal Vaccines
Locations: CenExel RCA Hollywood, Florida, United States

Precision Clinical Research Sunrise, Florida, United States

Meridian Clinical Research Savannah, Georgia, United States

Velocity Clinical Research Valparaiso, Indiana, United States

View all 13 locations

View Trial Details

Completed

Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

NCT05540028

Conditions: Pneumococcal Vaccines
Locations: Canadian Center for Vaccinology, IWK Health Centre Halifax, Nova Scotia, Canada

View Trial Details

Pneumococcal Vaccines

Pneumococcal Vaccines trial results

Related conditions